Graypoint LLC Boosts Stock Position in The Cooper Companies, Inc. (NASDAQ:COO)

Graypoint LLC grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 205.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,458 shares of the medical device company’s stock after buying an additional 4,347 shares during the quarter. Graypoint LLC’s holdings in Cooper Companies were worth $594,000 as of its most recent SEC filing.

A number of other hedge funds have also made changes to their positions in COO. Victory Capital Management Inc. lifted its holdings in Cooper Companies by 23.0% during the 3rd quarter. Victory Capital Management Inc. now owns 3,950,119 shares of the medical device company’s stock worth $435,856,000 after buying an additional 737,726 shares during the last quarter. Envestnet Asset Management Inc. lifted its stake in Cooper Companies by 3.7% during the second quarter. Envestnet Asset Management Inc. now owns 758,332 shares of the medical device company’s stock worth $66,202,000 after purchasing an additional 26,787 shares during the last quarter. Franklin Resources Inc. increased its stake in Cooper Companies by 194.0% during the third quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company’s stock valued at $5,265,000 after purchasing an additional 32,260 shares during the last quarter. Principal Financial Group Inc. raised its holdings in shares of Cooper Companies by 6.6% during the third quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company’s stock worth $26,295,000 after purchasing an additional 14,687 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of Cooper Companies by 13.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 4,930,022 shares of the medical device company’s stock worth $543,979,000 after buying an additional 573,908 shares during the last quarter. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Trading Down 1.7 %

Shares of NASDAQ:COO opened at $90.31 on Friday. The company has a 50 day moving average of $97.84 and a 200-day moving average of $98.84. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The firm has a market cap of $18.02 billion, a P/E ratio of 46.31, a P/E/G ratio of 2.40 and a beta of 0.99. The Cooper Companies, Inc. has a twelve month low of $84.76 and a twelve month high of $112.38.

Cooper Companies (NASDAQ:COO) last released its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. The firm had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the firm posted $0.87 earnings per share. The firm’s revenue for the quarter was up 9.8% compared to the same quarter last year. As a group, analysts anticipate that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on COO. Citigroup lowered their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating for the company in a research report on Friday, December 6th. Needham & Company LLC reiterated a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. Wells Fargo & Company boosted their price objective on Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, December 6th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Finally, Morgan Stanley reduced their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating for the company in a report on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $117.00.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.